AI reads skin biopsies to spot hidden lymphomas
NCT ID NCT07705386
First seen Jul 15, 2026 · Last updated Jul 16, 2026 · Updated 1 time
Summary
This study is developing and testing an artificial intelligence model that analyzes images of skin biopsies to tell the difference between malignant lymphomas (like mycosis fungoides) and benign conditions that look similar. The AI will be trained on hundreds of archived slides and compared against diagnoses made by expert dermatopathologists. If accurate, the tool could help doctors make faster, more consistent diagnoses, especially in places with limited access to specialists.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- AI-assisted histopathology image analysis
- What this could lead to
- If successful, this AI tool could help doctors diagnose rare skin lymphomas more accurately and quickly, reducing misdiagnosis and delays in treatment.
- What could go wrong
- The AI model is still in development and may not perform as well in real-world settings or on images from different sources. It also relies on archived slides, which may not represent all cases.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS LYMPHOPROLIFERATIVE DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kasr Al-Aini Hospitals, Cairo University
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to outsmart lymphoma resistance
- Massive T-Cell lymphoma database aims to unlock new insights
- Scientists investigate skin microbiome in rare lymphoma
- Researchers track rare skin cancers in kids over decades
- New drug shows promise for controlling rare skin cancers
- Engineered immune cells take aim at tough lymphomas in first human test